Given the intricate interplay between BBB disruption, inflammatory responses and ischemic brain injury, we aimed to investigate both structural BBB-related markers (e.g. occludin) and inflammatory markers (e.g. NLRP3 inflammasome) to evaluate their individual and combined prognostic value in AIS. The gene discussed is NLRP3; the disease is androgen insensitivity syndrome.